Akili (NASDAQ:AKLI) stock rose ~38% on Wednesday after the company reported results from a trial of video game-based therapy EndeavorRx to treat adults with attention ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback